Oncology & Cancer

Scientists advise caution in immunotherapy research

In a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology ...

Genetics

New drugs more likely to be approved if backed up by genetics

A new drug candidate is more likely to be approved for use if it targets a gene known to be linked to the disease; a finding that can help pharmaceutical companies to focus their drug development efforts. Emily King and colleagues ...

Medications

COVID-19: Physician co-authors analysis of antiviral drug

In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral drug remdesivir, clinical improvement was observed in 68% of patients treated, according to an analysis ...

page 7 from 40